FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022359228> ?p ?o ?g. }

• W2022359228 endingPage "1028" @default.
• W2022359228 startingPage "1023" @default.
• W2022359228 abstract "Thrombelastography has received renewed interest in the perioperative setting. The main determinants of thrombelastographic results are coagulation factor concentrations (various zymogens and fibrinogen) and platelet count; thus, platelet inhibition renders these assays mainly coagulation factor dependent. Assays with and without platelet inhibition are thus increasingly used to trigger and monitor replacement therapy with blood products. In this study, we evaluated the effect of factor XIII inhibition and additional glycoprotein (GP) IIb/IIIa blockade on (platelet-inhibited) whole blood thrombelastography and whether a modified routine assay (using factor XIII antibody) can be used to detect factor XIII deficiency.Normal whole blood was incubated with increasing amounts of a nonspecific antibody, an anti-GPIIb/IIIa antibody, or a neutralizing anti-factor XIII antibody; samples were analyzed with a tissue factor-activated and platelet-inhibited whole blood thrombelastographic assay. Clotting time, clot formation time, maximum clot firmness, and clot lysis at 60 min were evaluated in triplicate. Also, 25 whole blood routine samples were evaluated for factor XIII deficiency using a new thrombelastographic assay incorporating a factor XIII antibody and using a standard factor XIII assay for comparison.Although GPIIb/IIIa inhibition did not alter the results of the platelet-inhibited whole blood thrombelastography, factor XIII inhibition significantly reduced maximum clot firmness (P = 0.020) and increased clot formation time (P = 0.025) and clot lysis (P = 0.007), leaving clotting time unchanged; a ceiling effect seemed to be present with increasing antibody concentrations in whole blood (but not plasma). The thrombelastographic assay for factor XIII deficiency (<70% activity) had a 90% sensitivity and negative predictive value (area under receiver operating characteristic curve 0.803, P = 0.0015); for a deficiency <60%, sensitivity and negative predictive value were 100% (area under receiver operating characteristic curve 0.84, P = 0.0037).Factor XIII has significant impact on platelet-inhibited activated whole blood thrombelastography. This phenomenon should be considered when interpreting thrombelastographic results in the bleeding patient, especially when the results trigger procoagulant therapy. Antibody-mediated factor XIII inhibition can be used to establish thrombelastography-based assays to detect factor XIII deficiency." @default.
• W2022359228 created "2016-06-24" @default.
• W2022359228 creator A5001761071 @default.
• W2022359228 creator A5007268707 @default.
• W2022359228 creator A5041293041 @default.
• W2022359228 creator A5075437938 @default.
• W2022359228 creator A5078562014 @default.
• W2022359228 creator A5088217495 @default.
• W2022359228 date "2009-10-01" @default.
• W2022359228 modified "2023-10-14" @default.
• W2022359228 title "In Vitro Inhibition of Factor XIII Retards Clot Formation, Reduces Clot Firmness, and Increases Fibrinolytic Effects in Whole Blood" @default.
• W2022359228 cites W1583439696 @default.
• W2022359228 cites W1972469351 @default.
• W2022359228 cites W1974384227 @default.
• W2022359228 cites W1985018076 @default.
• W2022359228 cites W1996916932 @default.
• W2022359228 cites W2001922591 @default.
• W2022359228 cites W2003508727 @default.
• W2022359228 cites W2005696854 @default.
• W2022359228 cites W2012863747 @default.
• W2022359228 cites W2013310546 @default.
• W2022359228 cites W2025778465 @default.
• W2022359228 cites W2030522696 @default.
• W2022359228 cites W2038126255 @default.
• W2022359228 cites W2042893845 @default.
• W2022359228 cites W2043294207 @default.
• W2022359228 cites W2059953302 @default.
• W2022359228 cites W2061297183 @default.
• W2022359228 cites W2064098321 @default.
• W2022359228 cites W2067514841 @default.
• W2022359228 cites W2067790467 @default.
• W2022359228 cites W2068460773 @default.
• W2022359228 cites W2071415780 @default.
• W2022359228 cites W2090949044 @default.
• W2022359228 cites W2100768073 @default.
• W2022359228 cites W2122703802 @default.
• W2022359228 cites W2135559053 @default.
• W2022359228 cites W2136753338 @default.
• W2022359228 cites W2137423906 @default.
• W2022359228 cites W2144170468 @default.
• W2022359228 cites W2398383220 @default.
• W2022359228 cites W2416171463 @default.
• W2022359228 cites W2417600465 @default.
• W2022359228 cites W32567474 @default.
• W2022359228 cites W4242132457 @default.
• W2022359228 doi "https://doi.org/10.1213/ane.0b013e3181b5a263" @default.
• W2022359228 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19762725" @default.
• W2022359228 hasPublicationYear "2009" @default.
• W2022359228 type Work @default.
• W2022359228 sameAs 2022359228 @default.
• W2022359228 citedByCount "45" @default.
• W2022359228 countsByYear W20223592282012 @default.
• W2022359228 countsByYear W20223592282013 @default.
• W2022359228 countsByYear W20223592282014 @default.
• W2022359228 countsByYear W20223592282015 @default.
• W2022359228 countsByYear W20223592282016 @default.
• W2022359228 countsByYear W20223592282017 @default.
• W2022359228 countsByYear W20223592282018 @default.
• W2022359228 countsByYear W20223592282019 @default.
• W2022359228 countsByYear W20223592282020 @default.
• W2022359228 countsByYear W20223592282021 @default.
• W2022359228 countsByYear W20223592282022 @default.
• W2022359228 countsByYear W20223592282023 @default.
• W2022359228 crossrefType "journal-article" @default.
• W2022359228 hasAuthorship W2022359228A5001761071 @default.
• W2022359228 hasAuthorship W2022359228A5007268707 @default.
• W2022359228 hasAuthorship W2022359228A5041293041 @default.
• W2022359228 hasAuthorship W2022359228A5075437938 @default.
• W2022359228 hasAuthorship W2022359228A5078562014 @default.
• W2022359228 hasAuthorship W2022359228A5088217495 @default.
• W2022359228 hasBestOaLocation W20223592281 @default.
• W2022359228 hasConcept C126322002 @default.
• W2022359228 hasConcept C159654299 @default.
• W2022359228 hasConcept C1621761 @default.
• W2022359228 hasConcept C186738567 @default.
• W2022359228 hasConcept C203014093 @default.
• W2022359228 hasConcept C26809991 @default.
• W2022359228 hasConcept C2777664302 @default.
• W2022359228 hasConcept C2778382381 @default.
• W2022359228 hasConcept C2779036427 @default.
• W2022359228 hasConcept C2779672106 @default.
• W2022359228 hasConcept C2910686401 @default.
• W2022359228 hasConcept C54173615 @default.
• W2022359228 hasConcept C71924100 @default.
• W2022359228 hasConcept C77171857 @default.
• W2022359228 hasConcept C89560881 @default.
• W2022359228 hasConcept C98274493 @default.
• W2022359228 hasConceptScore W2022359228C126322002 @default.
• W2022359228 hasConceptScore W2022359228C159654299 @default.
• W2022359228 hasConceptScore W2022359228C1621761 @default.
• W2022359228 hasConceptScore W2022359228C186738567 @default.
• W2022359228 hasConceptScore W2022359228C203014093 @default.
• W2022359228 hasConceptScore W2022359228C26809991 @default.
• W2022359228 hasConceptScore W2022359228C2777664302 @default.
• W2022359228 hasConceptScore W2022359228C2778382381 @default.
• W2022359228 hasConceptScore W2022359228C2779036427 @default.
• W2022359228 hasConceptScore W2022359228C2779672106 @default.
• W2022359228 hasConceptScore W2022359228C2910686401 @default.

• next